Search research articles
Contact Us
Filters
Showing results (261-270 of 276) with videos related to
Page
of 28
Sort By:
Cancers
|
February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma
Michael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2024
Early versus late response to PD-1-based immunotherapy in metastatic melanoma
Georg C Lodde, Fang Zhao, Rudolf Herbst, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
Cindy Franklin, Peter Mohr, Leonie Bluhm, et al.
Lancet (London, England)
|
June 4, 2015
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, et al.
Nature Medicine
|
June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Nature Communications
|
March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasis
Anna Lorentzen, Paul F Becker, Jan Kosla, et al.
Nature Medicine
|
December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
The New England Journal of Medicine
|
September 30, 2014
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2022
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma
Inês Pires da Silva, Tasnia Ahmed, Jennifer L McQuade, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 276) with videos related to
Sort By:
Page
of 28
Cancers
|
February 27, 2026
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant Melanoma
Michael Weichenthal, Dirk Debus, Lisa Zimmer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2024
Early versus late response to PD-1-based immunotherapy in metastatic melanoma
Georg C Lodde, Fang Zhao, Rudolf Herbst, et al.
Journal for Immunotherapy of Cancer
|
June 10, 2022
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG
Cindy Franklin, Peter Mohr, Leonie Bluhm, et al.
Lancet (London, England)
|
June 4, 2015
Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2025
Sex-specific survival in advanced metastatic melanoma - a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG
Anna-Sophia Leven, Triinu Peters, Luisa Sophie Rajcsanyi, et al.
Nature Medicine
|
June 21, 2020
Author Correction: Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
Nature Communications
|
March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasis
Anna Lorentzen, Paul F Becker, Jan Kosla, et al.
Nature Medicine
|
December 4, 2019
Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma
David Liu, Bastian Schilling, Derek Liu, et al.
The New England Journal of Medicine
|
September 30, 2014
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma
Georgina V Long, Daniil Stroyakovskiy, Helen Gogas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2022
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma
Inês Pires da Silva, Tasnia Ahmed, Jennifer L McQuade, et al.
Page
of 28